Efficient Drug Development

TNO works with public and private parties to create and implement innovative technologies that make the process of drug development – from laboratory to patient – more efficient. This will make it possible to cut development costs and to get drugs to patients sooner.

Do you want to exchange knowledge?

Steven Erpelinck is happy to talk to you.

Contact me

Our latest developments

12 resultaten, getoond 6 t/m 10

Spatial Mass Spectrometry

Informatietype:
Article
Mass spectrometry imaging (MSI) provides tissue-level evidence of drug distribution, mechanism of action and molecular effects, supporting early drug development and disease research.
Read more
over Spatial Mass Spectrometry

Atherosclerosis

Informatietype:
Article
Read more
over Atherosclerosis

Preclinical ADME

Informatietype:
Article
Read more
over Preclinical ADME

Translational preclinical efficacy models

Informatietype:
Article
Read more
over Translational preclinical efficacy models

Data driven drug discovery

Informatietype:
Article
Read more
over Data driven drug discovery